Add to ORKGAbstract: Spike (S)-and nucleocapsid (N)-specific serological assay responses were determined before and/or after first dose SARS-CoV-2 vaccination in 22 individuals. S-specific assays quantified antibodies after vaccination with significant higher levels in participants with a previous infection. Be cautious combining N-/S-specific assay results, potentially differentiating post-infection/vaccination immunization as assay-specific N-anti-body waning was observed. (c) 2021 Elsevier Inc. All rights reserved
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characterist...
We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange County, CA., b...
Although antibody response to SARS-CoV-2 can be detected early during the infection, several outstan...
Objectives We investigated determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Multiple factors may be associated with immune responses to SARS-CoV-2 vaccines. Factors potentially...
Studies assessing the dynamics and duration of antibody responses following SARS-CoV-2 infection or ...
The current study aimed to determine to what extent prior COVID-19 infection affects the response of...
The current study aimed to determine to what extent prior COVID-19 infection affects the response of...
International audienceA better understanding of the anti-SARS-CoV-2 immune response is necessary to ...
Summary: Current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological tests are ...
The aim of this study was to characterize the antibody response induced by SARS-CoV-2 mRNA vaccines ...
Vaccination plays a key role in tackling the ongoing SARS-CoV-2 pandemic but data regarding the indi...
T-cell responses to SARS-CoV-2 following infection and vaccination are less characterized than antib...
Longitudinal data comparing SARS-CoV-2 serology in individuals following infection and vaccination o...
Neutralizing antibody (NAb) detection is critical for evaluating herd immunity and monitoring the ef...
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characterist...
We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange County, CA., b...
Although antibody response to SARS-CoV-2 can be detected early during the infection, several outstan...
Objectives We investigated determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV...
Multiple factors may be associated with immune responses to SARS-CoV-2 vaccines. Factors potentially...
Studies assessing the dynamics and duration of antibody responses following SARS-CoV-2 infection or ...
The current study aimed to determine to what extent prior COVID-19 infection affects the response of...
The current study aimed to determine to what extent prior COVID-19 infection affects the response of...
International audienceA better understanding of the anti-SARS-CoV-2 immune response is necessary to ...
Summary: Current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological tests are ...
The aim of this study was to characterize the antibody response induced by SARS-CoV-2 mRNA vaccines ...
Vaccination plays a key role in tackling the ongoing SARS-CoV-2 pandemic but data regarding the indi...
T-cell responses to SARS-CoV-2 following infection and vaccination are less characterized than antib...
Longitudinal data comparing SARS-CoV-2 serology in individuals following infection and vaccination o...
Neutralizing antibody (NAb) detection is critical for evaluating herd immunity and monitoring the ef...
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal characterist...
We analyzed data from two ongoing COVID-19 longitudinal serological surveys in Orange County, CA., b...
Although antibody response to SARS-CoV-2 can be detected early during the infection, several outstan...